Completed PHASE1 INTERVENTIONAL NCT00065741

Botanical/Drug Interactions in HIV: Glucuronidation

Sponsor: National Center for Complementary and Integrative Health (NCCIH)

Interventions silymarin

Updated 5 times since 2017 Last updated: Mar 21, 2007 Started: Sep 30, 2003 Completion: Mar 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00065741, this PHASE1 trial focuses on HIV Seronegativity and remains completed. Sponsored by National Center for Complementary and Integrative Health (NCCIH), it has been updated 5 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Complementary and Integrative Health (NCCIH)

Data source: National Center for Complementary and Integrative Health (NCCIH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chapel Hill, United States